4.0(top 10%)
impact factor
389(top 50%)
papers
5.0K(top 20%)
citations
34(top 20%)
h-index
4.1(top 10%)
impact factor
753
all documents
6.3K
doc citations
52(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer’s Diseasejournal of prevention of Alzheimer's disease, The2022201
2MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER'S DISEASE: DESIGN AND BASELINE DATAjournal of prevention of Alzheimer's disease, The2014149
3REVISITING THE CHOLINERGIC HYPOTHESIS IN ALZHEIMER’S DISEASE: EMERGING EVIDENCE FROM TRANSLATIONAL AND CLINICAL RESEARCHjournal of prevention of Alzheimer's disease, The2019135
4Aducanumab: Appropriate Use Recommendationsjournal of prevention of Alzheimer's disease, The2021115
5The Epidemiology of Alzheimer’s Disease Modifiable Risk Factors and Preventionjournal of prevention of Alzheimer's disease, The2021115
6MULTIDOMAIN INTERVENTIONS TO PREVENT COGNITIVE IMPAIRMENT, ALZHEIMER’S DISEASE, AND DEMENTIA: FROM FINGER TO WORLD-WIDE FINGERSjournal of prevention of Alzheimer's disease, The2020108
7MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER’S DISEASE: DESIGN AND BASELINE DATAjournal of prevention of Alzheimer's disease, The0106
8Female Sex and Alzheimer’s Risk: The Menopause Connectionjournal of prevention of Alzheimer's disease, The201894
9Diagnosis of Early Alzheimer’s Disease: Clinical Practice in 2021journal of prevention of Alzheimer's disease, The202190
10Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer's Disease and Other Tauopathiesjournal of prevention of Alzheimer's disease, The201790
11Mediterranean Diet and Magnetic Resonance Imaging-Assessed Brain Atrophy in Cognitively Normal Individuals at Risk for Alzheimer's Diseasejournal of prevention of Alzheimer's disease, The201480
12Clinical Development of Aducanumab, an Anti-Aβ Human Monoclonal Antibody Being Investigated for the Treatment of Early Alzheimer's Diseasejournal of prevention of Alzheimer's disease, The201770
13DEVELOPMENT OF AZELIRAGON, AN ORAL SMALL MOLECULE ANTAGONIST OF THE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS, FOR THE POTENTIAL SLOWING OF LOSS OF COGNITION IN MILD ALZHEIMER’S DISEASEjournal of prevention of Alzheimer's disease, The201867
14PRECISION MEDICINE - THE GOLDEN GATE FOR DETECTION, TREATMENT AND PREVENTION OF ALZHEIMER’S DISEASEjournal of prevention of Alzheimer's disease, The201667
15DEFINING DISEASE MODIFYING THERAPY FOR ALZHEIMER’S DISEASEjournal of prevention of Alzheimer's disease, The201765
16DIETARY FACTORS AND COGNITIVE DECLINEjournal of prevention of Alzheimer's disease, The201664
17BIFIDOBACTERIUM BREVE A1 SUPPLEMENTATION IMPROVED COGNITIVE DECLINE IN OLDER ADULTS WITH MILD COGNITIVE IMPAIRMENT: AN OPEN-LABEL, SINGLE-ARM STUDYjournal of prevention of Alzheimer's disease, The201959
18EARLY DETECTION OF MILD COGNITIVE IMPAIRMENT (MCI) IN PRIMARY CAREjournal of prevention of Alzheimer's disease, The202058
19NEUROPSYCHOLOGICAL PROFILE OF “COGNITIVE FRAILTY” SUBJECTS IN MAPT STUDYjournal of prevention of Alzheimer's disease, The201657
20REVISITING THE HALLMARKS OF AGING TO IDENTIFY MARKERS OF BIOLOGICAL AGEjournal of prevention of Alzheimer's disease, The202056
21BASELINE SUBJECTIVE MEMORY COMPLAINTS ASSOCIATE WITH INCREASED RISK OF INCIDENT DEMENTIA: THE PREADVISE TRIALjournal of prevention of Alzheimer's disease, The201555
22ANTI-TAU TRIALS FOR ALZHEIMER’S DISEASE: A REPORT FROM THE EU/US/CTAD TASK FORCEjournal of prevention of Alzheimer's disease, The201948
23THE ROAD AHEAD TO CURE ALZHEIMER\'S DISEASE: DEVELOPMENT OF BIOLOGICAL MARKERS AND NEUROIMAGING METHODS FOR PREVENTION TRIALS ACROSS ALL STAGES AND TARGET POPULATIONSjournal of prevention of Alzheimer's disease, The201448
24THE TIMECOURSE OF GLOBAL COGNITIVE GAINS FROM SUPERVISED COMPUTER-ASSISTED COGNITIVE TRAINING: A RANDOMISED, ACTIVE-CONTROLLED TRIAL IN ELDERLY WITH MULTIPLE DEMENTIA RISK FACTORSjournal of prevention of Alzheimer's disease, The201447
25COMPUTERIZED COGNITIVE TESTING FOR USE IN CLINICAL TRIALS: A COMPARISON OF THE NIH TOOLBOX AND COGSTATE C3 BATTERIESjournal of prevention of Alzheimer's disease, The201746
26ARIZONA ALZHEIMER’S REGISTRY: STRATEGY AND OUTCOMES OF A STATEWIDE RESEARCH RECRUITMENT REGISTRYjournal of prevention of Alzheimer's disease, The201446
27Lecanemab: Appropriate Use Recommendationsjournal of prevention of Alzheimer's disease, The046
28PIMAVANSERIN: POTENTIAL TREATMENT FOR DEMENTIA-RELATED PSYCHOSISjournal of prevention of Alzheimer's disease, The201844
29AADVAC1, AN ACTIVE IMMUNOTHERAPY FOR ALZHEIMER’S DISEASE AND NON ALZHEIMER TAUOPATHIES: AN OVERVIEW OF PRECLINICAL AND CLINICAL DEVELOPMENTjournal of prevention of Alzheimer's disease, The201944
30PLASMA BIOMARKERS OF AD EMERGING AS ESSENTIAL TOOLS FOR DRUG DEVELOPMENT: AN EU/US CTAD TASK FORCE REPORTjournal of prevention of Alzheimer's disease, The201943
31BLOOD-BRAIN BARRIER PERMEABILITY IN AGING AND ALZHEIMER’S DISEASEjournal of prevention of Alzheimer's disease, The201443
32MEDITERRANEAN DIET AND MAGNETIC RESONANCE IMAGING-ASSESSED BRAIN ATROPHY IN COGNITIVELY NORMAL INDIVIDUALS AT RISK FOR ALZHEIMER’S DISEASEjournal of prevention of Alzheimer's disease, The043
33INCREASED FUNCTIONAL CONNECTIVITY AFTER LISTENING TO FAVORED MUSIC IN ADULTS WITH ALZHEIMER DEMENTIAjournal of prevention of Alzheimer's disease, The201941
34PLASMA A?42/40 RATIO DETECTS EARLY STAGES OF ALZHEIMER’S DISEASE AND CORRELATES WITH CSF AND NEUROIMAGING BIOMARKERS IN THE AB255 STUDYjournal of prevention of Alzheimer's disease, The201941
35Neflamapimod: Clinical Phase 2b-Ready Oral Small Molecule Inhibitor of p38α to Reverse Synaptic Dysfunction in Early Alzheimer's Diseasejournal of prevention of Alzheimer's disease, The201741
36Aducanumab: Appropriate Use Recommendations Updatejournal of prevention of Alzheimer's disease, The202241
37THE FEASIBILITY OF AT-HOME IPAD COGNITIVE TESTING FOR USE IN CLINICAL TRIALSjournal of prevention of Alzheimer's disease, The201639
38RE-ENGINEERING ALZHEIMER CLINICAL TRIALS: GLOBAL ALZHEIMER’S PLATFORM NETWORKjournal of prevention of Alzheimer's disease, The201638
39EARLY DETECTION OF MILD COGNITIVE IMPAIRMENT (MCI) IN AN AT-HOME SETTINGjournal of prevention of Alzheimer's disease, The202038
40INTEGRATED CARE FOR OLDER PEOPLE AND THE IMPLEMENTATION IN THE INSPIRE CARE COHORTjournal of prevention of Alzheimer's disease, The202038
41STRONG RELATIONSHIP BETWEEN MALNUTRITION AND COGNITIVE FRAILTY IN THE SINGAPORE LONGITUDINAL AGEING STUDIES (SLAS-1 AND SLAS-2)journal of prevention of Alzheimer's disease, The201837
42RATIONALE FOR EARLY DIAGNOSIS OF MILD COGNITIVE IMPAIRMENT (MCI) SUPPORTED BY EMERGING DIGITAL TECHNOLOGIESjournal of prevention of Alzheimer's disease, The202037
43RATIONALE AND STRUCTURE FOR A NEW CENTER FOR STUDIES ON PREVENTION OF ALZHEIMER’S DISEASE (STOP-AD)journal of prevention of Alzheimer's disease, The201637
44BRIDGING THE TRANSLATION GAP: FROM DEMENTIA RISK ASSESSMENT TO ADVICE ON RISK REDUCTIONjournal of prevention of Alzheimer's disease, The201536
45REGISTRIES AND COHORTS TO ACCELERATE EARLY PHASE ALZHEIMER’S TRIALS. A REPORT FROM THE E.U./U.S. CLINICAL TRIALS IN ALZHEIMER’S DISEASE TASK FORCEjournal of prevention of Alzheimer's disease, The201636
46ENDPOINTS FOR PRE-DEMENTIA AD TRIALS: A REPORT FROM THE EU/US/CTAD TASK FORCEjournal of prevention of Alzheimer's disease, The201535
47COGNITIVE FRAILTY AND INCIDENCE OF DEMENTIA IN OLDER PERSONSjournal of prevention of Alzheimer's disease, The201834
48EVALUATION OF THE NEUROPROTECTIVE POTENTIAL OF N-ACETYLCYSTEINE FOR PREVENTION AND TREATMENT OF COGNITIVE AGING AND DEMENTIAjournal of prevention of Alzheimer's disease, The201734
49CLINICAL EFFECTS OF TRAMIPROSATE IN APOE4/4 HOMOZYGOUS PATIENTS WITH MILD ALZHEIMER’S DISEASE SUGGEST DISEASE MODIFICATION POTENTIALjournal of prevention of Alzheimer's disease, The201734
50THE FUTURE OF ANTI-AMYLOID TRIALSjournal of prevention of Alzheimer's disease, The202034